---
title: "Hemab Therapeutics presents new clinical data from HMB-002 in VWD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292409412.md"
description: "Hemab Therapeutics presents new clinical data from HMB-002 in VWD"
datetime: "2026-07-12T20:00:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292409412.md)
  - [en](https://longbridge.com/en/news/292409412.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292409412.md)
generator: "portal-rs"
---

# Hemab Therapeutics presents new clinical data from HMB-002 in VWD


### Related Stocks

- [COAG.US](https://longbridge.com/en/quote/COAG.US.md)

## Related News & Research

- [Hemab Advances Bleeding Disorder Pipeline](https://longbridge.com/en/news/292520096.md)
- [Hemab Therapeutics: Advancing Pipeline, Regulatory Momentum, and Solid Cash Runway Support Buy Rating with Unchanged $40 Price Target](https://longbridge.com/en/news/290992223.md)
- [Spero Therapeutics files $300M mixed securities shelf](https://longbridge.com/en/news/297380989.md)
- [Primecap Management Co. CA Makes New Investment in Palvella Therapeutics, Inc. $PVLA](https://longbridge.com/en/news/297156499.md)
- [Attovia Therapeutics, Inc. (ATTO) Initiated with a Buy at RBC Capital](https://longbridge.com/en/news/297470988.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**